-
PPM-18: iNOS and NF-κB Research Workflows
2026-08-14
PPM-18 is a practical tool for separating upstream NF-κB control of iNOS expression from direct nitric oxide synthase inhibition. This guide translates its macrophage and sepsis-research evidence into reproducible assay workflows, formulation controls, orthogonal readouts, and carefully bounded extensions to inflammation and bone biology.
-
Viral RIPK3 Degradation and Virus-Induced Inflammation
2026-08-14
Liu et al. identified a family of orthopoxvirus proteins, termed viral inducers of RIPK3 degradation, that recruit host SCF machinery to eliminate RIPK3 and suppress necroptosis. Genetic, biochemical, virological, and mouse experiments showed that this mechanism alters viral replication, inflammation, and mortality, revealing a direct connection between viral immune evasion and host–pathogen evolution.
-
Vitamin C in Senescence Assays: Practical Workflow
2026-08-13
Build a reproducible Vitamin C workflow for D-galactose-induced HEI-OC1 senescence, combining viability, ROS, β-galactosidase, p21, and NF-κB readouts. The same ascorbic acid product can also support carefully controlled cancer research, but dose, stability, and model-specific interpretation remain essential.
-
Muscle-Derived BDNF Directs Early NMJ Assembly
2026-08-13
The reference study shows that skeletal muscle locally traffics, processes, and releases BDNF at podosome-like structures to organize early acetylcholine receptor clustering during neuromuscular junction development. Its combined cell-culture, live-imaging, perturbation, and muscle-specific knockout strategy links spatially restricted BDNF signaling to the transition from aneural to nerve-induced postsynaptic apparatus.
-
SM-102: From LNP Mechanism to Localized mRNA Therapy
2026-08-12
SM-102 is more than a formulation ingredient: it is a translational design variable linking mRNA encapsulation, cellular uptake, endosomal escape, and route-specific exposure. This thought-leadership article examines how SM-102 can inform mRNA vaccine development while using a recent intravesical p21 mRNA–LNP study to identify the opportunities, validation requirements, and limitations involved in extending LNP strategies into localized cancer therapy.
-
p-Tau Ser356 and NUAK Inhibition in Alzheimer’s Disease
2026-08-12
This 2024 Acta Neuropathologica study characterizes p-tau Ser356 as a pathology-associated tau species in Alzheimer’s disease and shows that it responds differently to NUAK inhibition in mouse and adult human brain slice cultures. Its combination of neuropathology, array tomography, and ex vivo pharmacology provides a useful framework for evaluating site-specific tau biology and translational model limitations.
-
Caspase-3 Fluorometric Assay Kit Guide
2026-08-11
The Caspase-3 Fluorometric Assay Kit uses DEVD-AFC cleavage to support quantitative caspase activity measurement. K2007 provides a rapid fluorescence workflow for comparing DEVD-dependent activity in apoptotic samples and controls, while pathway conclusions require appropriate controls and orthogonal assays.
-
Patient-Derived Prostate Cancer Spheroid Models
2026-08-11
Linxweiler and colleagues established viable three-dimensional spheroids from organ-confined prostate cancer tissue obtained during radical prostatectomy, addressing a major gap between metastatic cell lines and primary disease. The model retained key epithelial and prostate cancer markers, supported cryopreservation and drug testing, and revealed stronger viability loss with bicalutamide and enzalutamide than with docetaxel or abiraterone.
-
KX2-391 as an Inhibitor of HBV Transcription
2026-08-10
Harada and colleagues identified KX2-391 through a recombinant HBV NanoLuc screening system and showed that it suppresses HBV transcription through tubulin polymerization inhibition rather than Src kinase inhibition. The study provides a useful host-directed antiviral workflow for distinguishing effects on viral entry, transcription, and replication.
-
A-1331852: BCL-XL Inhibitor Workflow
2026-08-09
A-1331852 provides a selective way to test BCL-XL dependence, apoptosis induction, and senescent-cell vulnerability in cancer research. This practical guide translates BH3-mimetic evidence into dose-response, mechanism, combination, and troubleshooting workflows without overstating preclinical findings.
-
Cyclosporin A in Mitophagy and Pyroptosis Studies
2026-08-08
Cyclosporin A enables controlled testing of cyclophilin-sensitive mitochondrial pathways alongside inflammatory-cell-death assays. This workflow translates findings from gouty arthritis research into practical strategies for autoimmune disorder research, apoptosis modulation, and carefully bounded translational models.
-
LIRP Enables Light-Controlled Gene Therapy
2026-08-07
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic mRNA translation with blue or ambient light. In animal models, LIRP-regulated AAV2 systems enabled reversible control of metabolic and retinal gene therapies, illustrating how translational regulation could improve timing and safety.
-
TG003 Cdc2-like Kinase Inhibitor: Workflows for Splicing & C
2026-08-07
TG003 unlocks new frontiers in alternative splicing research and platinum-resistant cancer modeling by delivering nanomolar inhibition of key Clk isoforms. This guide distills literature-backed protocols, troubleshooting tactics, and translational insights to help researchers harness TG003’s full potential in cellular, in vivo, and therapeutic exon-skipping studies.
-
Tacrine Hydrochloride Hydrate: Optimizing Neurodegenerative
2026-08-06
Tacrine hydrochloride hydrate (Tetrahydroaminacrine) stands as a benchmark tool for probing cholinergic dysfunction and neuroprotection in Alzheimer's disease research. This article details rigorous protocol enhancements, troubleshooting insight, and translational strategies that leverage APExBIO’s high-purity formulation for reproducible, high-impact results in neurodegenerative disease models.
-
NLRP10 Regulates Keratinocyte Survival and Skin Barrier in A
2026-08-06
The referenced study uncovers the critical role of NLRP10 in maintaining epidermal homeostasis through regulation of keratinocyte survival and P63-dependent differentiation. These findings clarify genetic links between NLRP10 and atopic dermatitis, highlighting NLRP10 as a potential therapeutic target for restoring skin barrier integrity.